Wearable Sensors to Track Movement in Progressive Supranuclear Palsy and Lewy Body Dementia
Checks wearable sensors that track arm and leg movement in these two conditions.
Plain-language title generated from the registry record
Registry title: Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
Key facts
- Where
- Boston and Lutherville, United StatesSee the 2 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 89 years old?
Source: NCT07240805, who can take part
Where in United States
- Massachusetts General HospitalBoston, United StatesNo longer taking part
- Johns Hopkins University School of MedicineLutherville, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- BioSensics
- Trial code
- NCT07240805
- Record updated
- 13 October 2026
- Original description
Progressive supranuclear palsy (PSP), mild cognitive impairment with Lewy bodies (MCI-LB), and Dementia with Lewy Bodies (DLB) are severe neurodegenerative diseases that cause significant motor impairment impacting daily function. Researchers at BioSensics, Johns Hopkins School of Medicine, Massachusetts General Hospital and their collaborators aim to conduct an analytical and clinical validation of wearable-based digital health technologies for monitoring upper and lower limb function in PSP, MCI-LB and DLB that could enable frequent, at-home monitoring and be incorporated into future clinical trials.Read full original descriptionShow less
Digital Health Technologies For Monitoring Disease Symptoms in Progressive Supranuclear Palsy and Dementia With Lewy Bodies
Progressive supranuclear palsy (PSP), mild cognitive impairment with Lewy bodies (MCI-LB), and Dementia with Lewy Bodies (DLB) are severe neurodegenerative diseases that cause significant motor impairment impacting daily function. Researchers at BioSensics, Johns Hopkins School of Medicine, Massachusetts General Hospital and their collaborators aim to conduct an analytical and clinical validation of wearable-based digital health technologies for monitoring upper and lower limb function in PSP, MCI-LB and DLB that could enable frequent, at-home monitoring and be incorporated into future clinical trials.
Inclusion: Male and female participants aged 40-89 meeting clinical diagnostic criteria for probable PSP, probable MCI-LB or probable DLB; Able to be present for all study procedures, complete questionnaires and assist during home data collection; Eligible participants must be fluent in reading and speaking English and must be capable of providing informed consent based on the principal investigator's judgment; Must have a caregiver or study partner who is willing and able to assist with all study-related procedures; Ambulatory (able to take 10 steps with minimal support such as use of a cane).
Exclusion: Any neurological, medical, or psychiatric condition that would preclude or confound participation in study activities based on the investigator's judgment; History of frequent falls defined as more than 5 falls per month, will not be eligible to participate in the study.